Discover Differentiated NK-Cell Binders
Improved Outcomes in NK Binder Discovery
NK-cell programs require binders that perform across heterogeneous receptor landscapes, enable efficient enrichment during screening, and remain suitable for downstream molecular reformatting. The AbNano® VHH Anti-NK-Cell Library combines peripheral NK-cell-derived repertoire diversity with core VHH structural advantages to support discovery across NK-associated targets.
Expanded epitope access
Expanded epitope access
Compact VHH domains and diverse CDR3 architectures support engagement of recessed, conformational, and sterically constrained targets that can be challenging for conventional antibody formats.
Higher-value hit generation
Higher-value hit generation
A target-relevant starting repertoire can improve screening efficiency and increase recovery of differentiated binders across NK-associated targets.
Stronger go / no-go decisions
Stronger go / no-go decisions
Sequencing, structural diversity characterization, and early target-specific validation data provide a stronger analytical foundation for candidate selection and program prioritization.
Broader downstream utility
Broader downstream utility
Qualified binders can be advanced into bispecifics, CAR-NK constructs, payload-bearing molecules, imaging agents, and half-life–extended designs.
Integrated path from library to lead
Integrated path from library to lead
Use the library for internal screening or combine it with AbNano discovery services for selection, sequence analysis, recombinant conversion, and lead progression.
What is a NK Cell?
What is a NK Cell?
Natural killer (NK) cells are cytotoxic group 1 innate lymphoid cells that lack somatically recombined antigen receptors and function as innate effector lymphocytes within tissue immune networks, contributing to early host defense and immune regulation (Vivier et al., 2023).
Vivier, E., et al. (2023). Innate lymphoid cells: 10 years on. J Allergy Clin Immunol, 151(2), 355–368.
Supported Research Areas
First-in-Class Peripheral NK-Cell-Derived VHH Library
The AbNano VHH Anti-NK-Cell Library leverages biologically relevant peripheral NK-cell targets and broad sequence diversity to enable productive binder discovery in a complex immune setting.
Programs centered on NK biology may benefit from a target- focused starting repertoire rather than a general-purpose library.
Evidence of Productive NK Binder Discovery
Broad Diversity Across Target Space
Next-generation sequencing identified CDR3 lengths spanning 5–30 amino acids, with enriched populations at 5, 9, and 11 residues. Broad structural diversity can expand opportunities to recover binders against recessed, conformational, and sterically constrained epitopes.
CDR3 Range
5–30 aa
Characterized by Sequencing
Figure 1. CDR3 length distribution derived from next-generation sequencing analysis of the AbNano VHH Anti-NK-Cell Library.
Balanced Architecture for Screening
CDR analysis showed expected conservation in framework-associated regions with broader diversity in CDR3, consistent with a repertoire suited for broad binding exploration and productive screening.
Figure 2. Position-specific amino acid distribution across representative CDR3 sequences mapped to Kabat numbering.
Validated Across Distinct NK Targets
Screening identified binders across multiple NK-associated targets with different biological roles.
Flexible Discovery Support for NK-Target Programs
The AbNano® VHH Anti-NK-Cell Library can be used independently or combined with tailored discovery support. This format gives teams a clearer view of how support can scale from early library evaluation through downstream progression.
Reduce Internal Workload
Offload screening, sequence review, and hit triage so internal teams stay focused on core priorities and strategic program decisions.
Access Specialized Workflows
Leverage phage display selection, sequence analysis, recombinant conversion, and binder progression workflows where additional expertise is needed.
Scale to Program Needs
Use the library independently, add targeted support, or engage integrated discovery services based on scope, timelines, and internal capacity.
Improve Program Continuity
Move from library access through candidate refinement within one coordinated support model, helping reduce handoff friction across stages.
Frequently Asked Questions
What are the advantages of an NK cell–derived VHH antibody library for target discovery?
An NK cell–derived VHH library incorporates immune-derived sequence diversity shaped by natural killer cell recognition of stressed and transformed cells. This introduces bias toward immune-relevant binding space and can improve recovery of binders associated with physiologically meaningful targets in immuno-oncology, including receptor–ligand and immune evasion pathways.
Why does peripheral NK-cell source material matter?
Peripheral NK cells capture functional heterogeneity across circulating subsets, including variation in receptor expression and activation state. Incorporating this diversity into a library can expand coverage of NK-associated targets and functional states not fully represented in synthetic or non-immune repertoires.
What NK-associated targets are commonly studied?
NK-focused programs investigate activating and inhibitory receptors such as NKG2D, NKp30, NKp46, KIRs, and NKG2A, as well as Fc receptor pathways (CD16) and stress ligands including MICA/B and ULBPs. These pathways regulate NK-cell activation, cytotoxic function, and tumor immune evasion.
How does CAR-NK research differ from CAR-T approaches?
CAR-NK research often emphasizes allogeneic use, innate cytotoxic mechanisms, and differentiated safety profiles. These factors influence design considerations such as persistence, cytokine release risk, and scalability in translational development.
How is the Anti-NK Cell Library different from the AbNano® VHH Naïve Library?
The Anti-NK Cell Library is derived from peripheral NK cell–associated immune diversity and is intended to enrich discovery within NK-related target space. The AbNano® VHH Naïve Library is a broad, non-targeted repertoire designed for discovery across diverse target classes.
Discuss Your Target
Use the form below to request information or start a conversation with our scientific team.
